Q1 2023 Net Revenue Increased 90% to
First Quarter 2023 Financial and Operating Highlights
-
Net revenue of
$3.5 million increased 90% year over year attributable to higher average selling prices and expanded go-to-market strategy that includes a direct in-country sales model. -
Commenced production of the LS400, Teemak and Metro electric commercial trucks at the Company’s new 100,000 sq. ft. assembly facility in
Jacksonville, FL. -
Commenced production of the LS400 and Metro electric commercial trucks at the company’s 40,000 sq. ft. assembly facility in
Howell, NJ ., in which 25,000 sq. ft. is dedicated to the LS 400 and the remaining 15,000 sq. ft. is dedicated for other models. -
Commenced assembly and production of battery packs using lithium iron phosphate (“LFP”) battery cells and proprietary battery management technologies in our
U.S. and German facilities for the Metro vehicle line. - Premiered five new vehicles at the 2023 Consumer Electronics Show (CES®), one of the world’s largest technology trade shows.
-
Achieved certification by the
California Air Resources Board for the LS400 , allowing the vehicle to be considered for monetary incentives including the California Hybrid andZero-Emission Truck and Bus Voucher Incentive Project (“HVIP”). -
Entered Central and Latin American markets by adding dealerships and making initial deliveries in
Mexico , theDominican Republic ,Honduras , andJamaica .
“The first quarter of 2023 was highlighted by the expansion of the
“In the
“During the first quarter of 2023 we also began to assemble and produce battery packs using lithium iron phosphate (“LFP”) battery cells and our proprietary battery management technologies at facilities in
“Along with the launch of our
“Looking ahead, we have built a strong foundation to support growth, based on a diverse lineup of all-electric vehicles and with production, distribution, and service infrastructure in place. Our expanded go-to-market model along with our direct sales model is beginning to gain traction with customers across the globe such as in the
“The average selling price ('ASP') was approximately
First Quarter 2023 Financial Results
Net Revenues
Net revenue was approximately
Gross Profit
Gross profit was approximately
Operating Expenses
Total operating expenses were approximately
Net Loss Attributable to the Company’s Shareholders
Net loss was approximately
Balance Sheet
Cash and cash equivalents were approximately
Adjusted EBITDA1
Adjusted EBITDA was approximately
We define Adjusted EBITDA as net (loss)/income before net interest expense, income tax expense and depreciation and amortization as further adjusted to exclude the impact of stock-based compensation expense and non-recurring expenses. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by our industry peers because not all companies and analysts calculate Adjusted EBITDA in the same manner. We present Adjusted EBITDA because we consider it to be an important supplemental measure of our performance and believe it is frequently used by securities analysts, investors, and other interested parties in the evaluation of companies in our industry. Management believes that investors’ understanding of our performance is enhanced by including this non-GAAP financial measure as a reasonable basis for comparing our ongoing results of operations.
US-GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA RECONCILIATION
|
Three Months Ended |
|||||
|
2023 |
2022 |
||||
(Expressed in |
(Unaudited) |
|||||
Net loss |
$ |
(11,113,977 |
) |
$ |
(9,348,369 |
) |
Interest expense, net |
|
54,415 |
|
|
(64,201 |
) |
Income tax expense |
|
— |
|
|
— |
|
Depreciation and amortization |
|
330,632 |
|
|
140,430 |
|
Share-based compensation expense |
|
1,153,808 |
|
|
199,416 |
|
Loss on redemption of convertible promissory notes |
|
2,001 |
|
|
- |
|
Loss on exercise of warrants |
|
212,870 |
|
|
||
Change in fair value of convertible promissory notes and derivative liability |
|
126,272 |
|
|
- |
|
Expenses related to one-off payment inherited from the original |
|
|
8,299,178 |
|
||
Adjusted EBITDA |
$ |
(9,233,979 |
) |
$ |
(773,546 |
) |
1 Represents a non-GAAP financial measure.
About
Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of the safe harbor provisions of the
CONSOLIDATED BALANCE SHEETS
(Expressed in |
||||||||
|
|
Mach 31,
|
|
|
||||
|
|
(Unaudited) |
|
|
||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
91,847,734 |
|
|
$ |
153,966,777 |
|
Restricted cash |
|
|
92,461 |
|
|
|
130,024 |
|
Accounts receivable, net |
|
|
2,732,834 |
|
|
|
565,398 |
|
Inventories |
|
|
36,546,917 |
|
|
|
31,843,371 |
|
Prepayment and other current assets |
|
|
15,596,764 |
|
|
|
16,138,330 |
|
Deferred cost- current |
|
|
20,026 |
|
|
|
- |
|
Amounts due from related parties |
|
|
343,353 |
|
|
|
366,936 |
|
Total current assets |
|
|
147,180,089 |
|
|
|
203,010,836 |
|
|
|
|
|
|
|
|
||
Non-current assets: |
|
|
|
|
|
|
||
Long-term investment, net |
|
|
5,239,512 |
|
|
|
5,325,741 |
|
Investment in equity securities |
|
|
30,412,211 |
|
|
|
29,759,195 |
|
Property, plant and equipment, net |
|
|
17,265,446 |
|
|
|
14,962,591 |
|
Intangible assets, net |
|
|
4,558,185 |
|
|
|
4,563,792 |
|
Right-of-use assets |
|
|
13,865,063 |
|
|
|
8,187,149 |
|
Deferred cost- non-current |
|
|
243,251 |
|
|
|
- |
|
Other non-current assets, net |
|
|
2,306,597 |
|
|
|
2,039,012 |
|
Total non-current assets |
|
|
73,890,265 |
|
|
|
64,837,480 |
|
|
|
|
|
|
|
|
||
Total Assets |
|
$ |
221,070,354 |
|
|
$ |
267,848,316 |
|
|
|
|
|
|
|
|
||
LIABILITIES AND EQUITY |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
LIABILITIES |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
2,899,119 |
|
|
$ |
3,383,021 |
|
Accrued expenses and other current liabilities |
|
|
3,668,415 |
|
|
|
5,048,641 |
|
Contractual liabilities |
|
|
2,656,151 |
|
|
|
2,388,480 |
|
Operating lease liabilities, current |
|
|
2,779,279 |
|
|
|
1,313,334 |
|
Convertible promissory notes |
|
|
17,903,274 |
|
|
|
57,372,827 |
|
Deferred government grant, current |
|
|
56,009 |
|
|
|
26,533 |
|
Amounts due to related parties |
|
|
46,900 |
|
|
|
716,372 |
|
Total current liabilities |
|
|
30,009,147 |
|
|
|
70,249,208 |
|
|
|
|
|
|
|
|
||
Non-current liabilities: |
|
|
|
|
|
|
||
Deferred government grant, non-current |
|
|
1,036,172 |
|
|
|
497,484 |
|
Derivative liability - investor warrant |
|
|
12,392,632 |
|
|
|
14,334,104 |
|
Derivative liability - placement agent warrant |
|
|
3,457,067 |
|
|
|
3,456,404 |
|
Operating lease liabilities, non-current |
|
|
11,640,499 |
|
|
|
7,421,582 |
|
Total non-current liabilities |
|
|
28,526,370 |
|
|
|
25,709,574 |
|
|
|
|
|
|
|
|
||
Total Liabilities |
|
$ |
58,535,517 |
|
|
$ |
95,958,782 |
|
|
|
|
|
|
|
|
||
Commitments and contingencies |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
EQUITY |
|
|
|
|
|
|
||
Ordinary shares (No par value; 304,449,091 and 300,841,995 shares issued and outstanding as of |
|
|
- |
|
|
|
- |
|
Additional paid in capital |
|
|
398,262,089 |
|
|
|
397,497,817 |
|
Accumulated deficit |
|
|
(230,782,125 |
) |
|
|
(219,824,176 |
) |
Accumulated other comprehensive loss |
|
|
(4,945,127 |
) |
|
|
(5,306,972 |
) |
Total equity attributable to shareholders |
|
|
162,534,837 |
|
|
|
172,366,669 |
|
Non-controlling interests |
|
|
- |
|
|
|
(477,135 |
) |
Total Equity |
|
$ |
162,534,837 |
|
|
$ |
171,889,534 |
|
Total Liabilities and Equity |
|
$ |
221,070,354 |
|
|
$ |
267,848,316 |
|
CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Expressed in |
||||||||
|
|
For the Three Months Ended |
||||||
|
|
2023 |
|
2022 |
||||
|
|
|
|
|
||||
Net revenues |
|
$ |
3,470,544 |
|
|
$ |
1,830,633 |
|
Cost of goods sold |
|
|
(3,275,800 |
) |
|
|
(1,467,603 |
) |
Gross profit |
|
|
194,744 |
|
|
|
363,030 |
|
|
|
|
|
|
|
|
||
OPERATING EXPENSES: |
|
|
|
|
|
|
||
Selling and marketing expenses |
|
|
(1,868,985 |
) |
|
|
(1,095,108 |
) |
General and administrative expenses |
|
|
(7,358,264 |
) |
|
|
(8,211,831 |
) |
Research and development expenses |
|
|
(1,569,919 |
) |
|
|
(425,359 |
) |
Total operating expenses |
|
|
(10,797,168 |
) |
|
|
(9,732,298 |
) |
|
|
|
|
|
|
|
||
Loss from operations |
|
|
(10,602,424 |
) |
|
|
(9,369,268 |
) |
|
|
|
|
|
|
|
||
OTHER EXPENSE: |
|
|
|
|
|
|
||
Interest (expense) income, net |
|
|
(54,415 |
) |
|
|
64,201 |
|
Income from long-term investment |
|
|
19,042 |
|
|
|
5,937 |
|
Impairment of long-term investment |
|
|
(1,146,128 |
) |
|
|
- |
|
Loss on redemption of convertible promissory notes |
|
|
(2,001 |
) |
|
|
- |
|
Loss on exercise of warrants |
|
|
(212,870 |
) |
|
|
- |
|
Change in fair value of convertible promissory notes and derivative liability |
|
|
(126,273 |
) |
|
|
- |
|
Change in fair value of equity securities |
|
|
653,016 |
|
|
|
- |
|
Other income (expense), net |
|
|
358,076 |
|
|
|
(49,239 |
) |
Loss before income taxes |
|
|
(11,113,977 |
) |
|
|
(9,348,369 |
) |
Income tax expense |
|
|
- |
|
|
|
- |
|
Net loss |
|
|
(11,113,977 |
) |
|
|
(9,348,369 |
) |
Less: net loss attributable to non-controlling interests |
|
|
(156,028 |
) |
|
|
(36,719 |
) |
Net loss attributable to the Company’s shareholders |
|
$ |
(10,957,949 |
) |
|
$ |
(9,311,650 |
) |
|
|
|
|
|
|
|
||
OTHER COMPREHENSIVE LOSS |
|
|
|
|
|
|
||
Foreign currency translation adjustment |
|
|
337,278 |
|
|
|
253,156 |
|
Total comprehensive loss |
|
|
(10,776,699 |
) |
|
|
(9,095,213 |
) |
|
|
|
|
|
|
|
||
Less: total comprehensive loss attributable to non-controlling interests |
|
|
(180,595 |
) |
|
|
(57,588 |
) |
Total comprehensive loss to the Company’s shareholders |
|
$ |
(10,596,104 |
) |
|
$ |
(9,037,625 |
) |
CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOW
(Expressed in |
||||||||
|
|
For the Three Months Ended |
||||||
|
|
2023 |
|
2022 |
||||
|
|
|
|
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
||||
Net cash used in operating activities |
|
$ |
(17,363,332 |
) |
|
$ |
(23,486,438 |
) |
|
|
|
|
|
|
|
||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
||
Purchase of equity investment |
|
|
(622,917 |
) |
|
|
- |
|
Purchase of plant and equipment |
|
|
(2,577,292 |
) |
|
|
(82,799 |
) |
Purchase of land use right and property |
|
|
(268,993 |
) |
|
|
- |
|
Acquisition of CAE's equity interests |
|
|
(1,924,557 |
) |
|
|
(2,843,003 |
) |
Proceeds from disposal of property, plant and equipment |
|
|
- |
|
|
|
327 |
|
Loans provided to third parties |
|
|
(100,000 |
) |
|
|
(1,047,053 |
) |
Net cash used in investing activities |
|
|
(5,493,759 |
) |
|
|
(3,972,528 |
) |
|
|
|
|
|
|
|
||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
||
Repayment of loans to related parties |
|
|
- |
|
|
|
(1,750,367 |
) |
Repayment of loans to third parties |
|
|
- |
|
|
|
(421,222 |
) |
Purchase of CAE’s loan |
|
|
- |
|
|
|
(13,228,101 |
) |
Reduction of capital |
|
|
- |
|
|
|
(13,930,000 |
) |
Redemption of convertible promissory notes |
|
|
(39,583,321 |
) |
|
|
- |
|
Payment of expense for the reverse recapitalization |
|
|
- |
|
|
|
(904,843 |
) |
Net cash used in financing activities |
|
|
(39,583,321 |
) |
|
|
(30,234,533 |
) |
|
|
|
|
|
|
|
||
Effect of exchange rate changes on cash |
|
|
283,806 |
|
|
|
97,755 |
|
|
|
|
|
|
|
|
||
Net decrease in cash, cash equivalents and restricted cash |
|
|
(62,156,606 |
) |
|
|
(57,595,744 |
) |
Cash, cash equivalents and restricted cash at beginning of period |
|
|
154,096,801 |
|
|
|
261,664,962 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
91,940,195 |
|
|
$ |
204,069,218 |
|
|
|
|
|
|
|
|
||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: |
|
|
|
|
|
|
||
Interest paid |
|
$ |
- |
|
|
$ |
377,717 |
|
|
|
|
|
|
|
|
||
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: |
|
|
|
|
|
|
||
Cashless exercise of warrants |
|
$ |
2,168,185 |
|
|
$ |
- |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230725914515/en/
Investor Relations Contact:
CENN@mzgroup.us
949-491-8235
Company Contact:
PR@cenntroauto.com
IR@cenntroauto.com
Source: